Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

152
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial exploration of the health effects on Qinghai-Tibetan Plateau yaks following short-term exposure to polystyrene microplastics: Analysis of rumen microbiota, host metabolism, antioxidant function and inflammatory responses.

Journal of hazardous materials·2026
Same author

Shengmai Liquid (Chinese patent medicine) for the treatment of post-COVID-19 fatigue: A protocol for a randomized, double-blind, placebo-controlled trial.

Complementary medicine research·2026
Same author

W-doped ZnO nanofibers for enhanced triethylamine sensing via electronic structure modulation.

Talanta·2026
Same author

1D Fully sp<sup>2</sup> Carbon-Linked Covalent Organic Frameworks for Powerful Photoreduction of CO<sub>2</sub>.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Effects of Cocamidopropyl Betaine on In Vitro Rumen Fermentation and Enzyme Spatial Distribution, and In Vivo Digestibility and Growth Performance of Growing Yaks.

Animals : an open access journal from MDPI·2026
Same author

Supplementation of bee pollen in high concentrate diets enhances the health status and production performance of goats.

Frontiers in veterinary science·2026

Related Experiment Video

Updated: Apr 19, 2026

Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth with a Dense Interface
08:26

Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth with a Dense Interface

Published on: July 10, 2014

15.6K

Controlled release by novel lysostaphin-loaded hydroxyapatite/chitosan composites.

Jin-Cheng Wang, Bai Xue, Kui-Kui Ge

    Yao Xue Xue Bao = Acta Pharmaceutica Sinica
    |December 19, 2014
    PubMed
    Summary

    Hydroxyapatite/chitosan composites effectively deliver lysostaphin for eliminating MRSA. These biocompatible materials show promise for bone infection treatments due to controlled drug release and enhanced cell growth.

    More Related Videos

    Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications
    05:41

    Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications

    Published on: February 23, 2017

    20.2K
    Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
    05:26

    Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

    Published on: April 13, 2022

    4.2K

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth with a Dense Interface
    08:26

    Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth with a Dense Interface

    Published on: July 10, 2014

    15.6K
    Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications
    05:41

    Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications

    Published on: February 23, 2017

    20.2K
    Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
    05:26

    Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

    Published on: April 13, 2022

    4.2K

    Area of Science:

    • Biomaterials Science
    • Drug Delivery Systems
    • Infectious Disease Research

    Background:

    • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant clinical challenge.
    • Lysostaphin is a potent agent against MRSA but requires effective delivery systems.
    • Biocompatible carriers are essential for controlled drug release in therapeutic applications.

    Purpose of the Study:

    • To develop and evaluate hydroxyapatite/chitosan (HA/CS) composites as carriers for lysostaphin.
    • To investigate the controlled release kinetics and in vitro biocompatibility of HA/CS composites loaded with lysostaphin.
    • To assess the potential of these composites for bone injury and infection applications.

    Main Methods:

    • Preparation of HA/CS composites with varying weight ratios (80/20, 70/30, 60/40, 40/60).
    • Characterization using scanning electron microscopy, X-ray diffraction, and Fourier transform infrared spectroscopy.
    • In vitro release studies of lysostaphin and biocompatibility testing with MC3T3-E1 cells.

    Main Results:

    • The 60/40 HA/CS composite exhibited the highest lysostaphin release rate of 87.4 ± 2.8% over 120 hours.
    • MC3T3-E1 cells demonstrated proliferation on the composite surfaces.
    • Extracts from the HA/CS composites promoted cell growth, indicating good biocompatibility.

    Conclusions:

    • HA/CS composites facilitate the controlled release of lysostaphin.
    • These composites possess excellent biocompatibility, supporting cell proliferation and growth.
    • The developed HA/CS/lysostaphin system shows significant potential for treating bone injuries and infections.